P 125 (Everolimus 5 mg)
Pill with imprint P 125 is White, Capsule-shape and has been identified as Everolimus 5 mg. It is supplied by Par Pharmaceutical, Inc.
Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma; pancreatic cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for P 125
Everolimus
- Imprint
- P 125
- Strength
- 5 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 49884-0125
Related images for "P 125"
More about everolimus
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (24)
- Drug images
- Pricing & coupons
- En español
- Drug class: mTOR inhibitors
Patient resources
- Drug Information
- Everolimus (Advanced Reading)
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
Other brands
Afinitor, Zortress, Afinitor Disperz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.